Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, CRISPR Therapeutics AG’s stock clocked out at $56.41, up 1.35% from its previous closing price of $55.66. In other words, the price has increased by $1.35 from its previous closing price. On the day, 1.19 million shares were traded. CRSP stock price reached its highest trading level at $58.675 during the session, while it also had its lowest trading level at $55.56.
Ratios:
To gain a deeper understanding of CRSP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.54 and its Current Ratio is at 17.54. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
On December 11, 2023, TD Cowen Downgraded its rating to Underperform which previously was Market Perform but kept the price unchanged to $30.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 15 ’24 when Kulkarni Samarth sold 19,582 shares for $59.91 per share. The transaction valued at 1,173,232 led to the insider holds 208,122 shares of the business.
Kulkarni Samarth sold 20,000 shares of CRSP for $1,449,628 on Mar 15 ’24. The Chief Executive Officer now owns 208,122 shares after completing the transaction at $72.48 per share. On Mar 15 ’24, another insider, Prasad Raju, who serves as the Chief Financial Officer of the company, sold 3,524 shares for $72.69 each. As a result, the insider received 256,160 and left with 6,476 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRSP now has a Market Capitalization of 4788255744 and an Enterprise Value of 3013099264. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.90 while its Price-to-Book (P/B) ratio in mrq is 2.40. Its current Enterprise Value per Revenue stands at 8.117 whereas that against EBITDA is -14.865.
Stock Price History:
Over the past 52 weeks, CRSP has reached a high of $91.10, while it has fallen to a 52-week low of $37.55. The 50-Day Moving Average of the stock is -22.15%, while the 200-Day Moving Average is calculated to be -5.31%.
Shares Statistics:
It appears that CRSP traded 1.76M shares on average per day over the past three months and 1388100 shares per day over the past ten days. A total of 84.88M shares are outstanding, with a floating share count of 80.46M. Insiders hold about 5.21% of the company’s shares, while institutions hold 65.75% stake in the company. Shares short for CRSP as of 1711584000 were 14757233 with a Short Ratio of 8.39, compared to 1709164800 on 15061974. Therefore, it implies a Short% of Shares Outstanding of 14757233 and a Short% of Float of 18.63.
